CN109512878A - The method that thick grass acid content improves in loose Pueraria lobota anti-trioxypurine particle preparation - Google Patents

The method that thick grass acid content improves in loose Pueraria lobota anti-trioxypurine particle preparation Download PDF

Info

Publication number
CN109512878A
CN109512878A CN201811562974.3A CN201811562974A CN109512878A CN 109512878 A CN109512878 A CN 109512878A CN 201811562974 A CN201811562974 A CN 201811562974A CN 109512878 A CN109512878 A CN 109512878A
Authority
CN
China
Prior art keywords
trioxypurine
loose
extract
pueraria lobota
acid content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811562974.3A
Other languages
Chinese (zh)
Inventor
王强
戚军
阮晓
郑波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAIKANG TAXUS CHINENSIS BIOLOGICAL ENGINEERING Co Ltd NINGBO CITY
Original Assignee
TAIKANG TAXUS CHINENSIS BIOLOGICAL ENGINEERING Co Ltd NINGBO CITY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TAIKANG TAXUS CHINENSIS BIOLOGICAL ENGINEERING Co Ltd NINGBO CITY filed Critical TAIKANG TAXUS CHINENSIS BIOLOGICAL ENGINEERING Co Ltd NINGBO CITY
Priority to CN201811562974.3A priority Critical patent/CN109512878A/en
Publication of CN109512878A publication Critical patent/CN109512878A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/15Pinaceae (Pine family), e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488Pueraria (kudzu)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/37Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/55Liquid-liquid separation; Phase separation

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses the methods that thick grass acid content in loose Pueraria lobota anti-trioxypurine particle preparation improves, pass through supercritical extract, wherein entrainer is by by ethyl alcohol, hexamethylene, petroleum ether, water is formulated according to mass ratio 5:1:1:3, shikimic acid extracts abundant, the absorbing liquid of methanol absorption chromatographs crude separation with macroreticular resin, obtain faint yellow loose Pueraria lobota anti-trioxypurine extract, with UPLC- diode array detector standard substance quantified by external standard method, thick grass acid content is 17.0~18.3mg/g in loose Pueraria lobota anti-trioxypurine extract, extracting method of the invention is simple, loose Pueraria lobota anti-trioxypurine extract thick grass acid content improves, extract main ingredient also has stronger anti-trioxypurine activity.

Description

The method that thick grass acid content improves in loose Pueraria lobota anti-trioxypurine particle preparation
Technical field
The present invention relates to the improvement methods of active constituent content in Chinese herbal granules preparation, and in particular to loose Pueraria lobota anti-trioxypurine The method that thick grass acid content improves in grain preparation.
Background technique
Hyperuricemia (Hyperuricemia, HUA) is one group disorderly with heredity and (or) acquired internal purine metabolism Unrest and (or) uric acid (UA) excretion reduce caused disease.When biosynthesis of purine excessive, internal rich in purine food intake When obstacle and renal tubule reduce the clearance rate of lithate, it may occur in which that circulation Uric Acid Content increases, lead to antihyperuricemic The morbidity of disease.For loose Pueraria lobota anti-trioxypurine particle by pine needle, pueraria lobata, three taste Chinese medicinal composition of dried orange peel, pine needle is Pinaceae pine genus plant masson pinePinus massoniana Lamb. dried leaf, whole year can adopt, and remove impurity, and sun drying or low temperature drying is used, it is cut into about 4~ The section of 10mm.Pueraria lobata source are as follows: legume pueraria lobataPueraria lobata (Willd.) dry root of Ohwi is practised and claims open country Pueraria lobota, autumn, the excavation of two season of winter take advantage of fresh-cut into the fritter of side length about 5~12mm, drying.Dried orange peel source are as follows: rutaceae orangeCitrus reticulate Blanco and its dry mature skin of variety, medicinal material are divided into " dried orange peel " and " citrus chachiensis hortorum ", Harvesting ripe fruit strips pericarp, chopping, sun drying or low temperature drying.Coastal Area in Zhejiang Province especially Ningbo area it is civil with Tea bag form is taken, dispel pathogenic wind and remove dampness, be clearing heat and detoxicating, strengthening the spleen and reducing phlegm the effect of, cure mainly phlegm stagnation (wet turbid), retention of damp-heat in the interior Type hyperuricemia.Loose Pueraria lobota anti-trioxypurine particle is exactly to be crushed with pine needle, pueraria lobata, dried orange peel, extract effective ingredient, along with medicinal Auxiliary material is prepared.
Summary of the invention
Technical problem to be solved by the invention is to provide the sides that thick grass acid content in loose Pueraria lobota anti-trioxypurine particle preparation improves Method, this method are extracted simply, and shikimic acid extracts sufficiently, and main ingredient also has stronger anti-trioxypurine in loose Pueraria lobota anti-trioxypurine extract Activity.
The technical scheme of the invention to solve the technical problem is: shikimic acid contains in loose Pueraria lobota anti-trioxypurine particle preparation The method improved is measured, its step are as follows:
A, the traditional Chinese medicinal material raw materials for preparing pine needle, pueraria lobata, dried orange peel 4.5~4.75:4.5 in mass ratio~4.75:0.5~1 crush Afterwards, 45~60 meshes are crossed, traditional Chinese medicinal material raw materials powder is obtained, is fitted into supercritical extraction reactor;
B, it is extracted in supercritical extraction reactor, extraction temperature is 35~55 DEG C, CO2Fluid pressure is 30~60MPa, entrainer stream 0.1~0.6ml/min of speed, 2~4h of extraction time, extract is absorbing liquid, methanol and traditional Chinese medicinal material raw materials powder with methanol absorption Volume mass ratio be 1ml:2g;The entrainer by ethyl alcohol, hexamethylene, petroleum ether, water according to mass ratio 5:1:1:3 prepare and At;Shikimic acid in medicinal material can be proposed that sufficiently other compositions decrease instead by the entrainer;
C, absorbing liquid with D101 type macroreticular resin chromatograph, per hour the distilled water of two bed volume flow velocitys be eluted to efflux without Color, then pillar is washed with the ethyl alcohol of the mass percentage concentration 75% of 10 bed volumes, ethanol eluate is under the conditions of 450~500Pa It is concentrated under reduced pressure into and closely does, 105 DEG C of dryings for 24 hours, obtain faint yellow loose Pueraria lobota anti-trioxypurine extract.Weighing, then loose Pueraria lobota anti-trioxypurine mentions It takes object using UPLC- diode array detector standard substance quantified by external standard method, obtains the higher loose Pueraria lobota drop urine of thick grass acid content Sour extract, then Chinese materia medica preparation pine Pueraria lobota anti-trioxypurine particle is configured to pharmaceutic adjuvant.
Compared with the prior art, the advantages of the present invention are as follows the sides that thick grass acid content in loose Pueraria lobota anti-trioxypurine particle preparation improves Method, by supercritical extract, wherein entrainer by being prepared by ethyl alcohol, hexamethylene, petroleum ether, water according to mass ratio 5:1:1:3 and At shikimic acid extracts sufficiently, and the absorbing liquid of methanol absorption chromatographs crude separation with macroreticular resin, obtains faint yellow loose Pueraria lobota anti-trioxypurine and mentions Object is taken, with UPLC- diode array detector standard substance quantified by external standard method, thick grass acid content is in loose Pueraria lobota anti-trioxypurine extract 17.0~18.3mg/g, extracting method of the invention is simple, and loose Pueraria lobota anti-trioxypurine extract thick grass acid content improves, and extract is main Composition also has stronger anti-trioxypurine activity.
Specific embodiment
Present invention is further described in detail with reference to embodiments.
Embodiment 1
The traditional Chinese medicinal material raw materials 100g that pine needle, pueraria lobata, dried orange peel 4.5~4.75:4.5 in mass ratio~4.75:0.5~1 are prepared, powder After broken, 45~60 meshes to be crossed, traditional Chinese medicinal material raw materials powder is obtained, is fitted into supercritical extraction reactor and extracts, extraction temperature is 45 DEG C, CO2Fluid pressure is 43MPa, and entrainer flow velocity 0.45ml/min, entrainer is by ethyl alcohol, hexamethylene, petroleum ether, water according to quality It is formulated than 5:1:1:3, which can propose shikimic acid in medicinal material sufficiently, extraction time 2.6h, extract 50ml Methanol absorption is absorbing liquid, and absorbing liquid is chromatographed with D101 type macroreticular resin, per hour the distillation washing of two bed volume flow velocitys Take off colourless to efflux, then wash pillar with 75% ethyl alcohol of mass percentage concentration of 10 bed volumes, ethanol eluate 450~ It is concentrated under reduced pressure under the conditions of 500Pa and closely does, 105 DEG C of dryings for 24 hours, obtain faint yellow loose Pueraria lobota anti-trioxypurine extract 1.94g, loose Pueraria lobota drop Uric acid extract uses UPLC- diode array detector standard substance quantified by external standard method, shikimic acid component content in extract For 17.8 mg/g, therefore shikimic acid extracts sufficiently, then is configured to Chinese materia medica preparation pine Pueraria lobota anti-trioxypurine particle with pharmaceutic adjuvant.
Embodiment 2
Substantially the same manner as Example 1, different only extraction temperatures are 35 DEG C, CO2Fluid pressure is 30MPa, entrainer stream Fast 0.1ml/min, extraction time 4h, obtain faint yellow loose Pueraria lobota anti-trioxypurine extract 1.92g, and extract species thick grass sour component contains Amount is 17.6 mg/g.
Embodiment 3
Substantially the same manner as Example 1, different only extraction temperatures are 55 DEG C, CO2Fluid pressure is 60MPa, entrainer stream Fast 0.6ml/min, extraction time 2h, obtain faint yellow loose Pueraria lobota anti-trioxypurine extract 1.91g, and extract species isoflavones components contain Amount is 17.5 mg/g.
Test example 1
The influence that hyperuricemia model mouse is caused to yeast extract+Oteracil Potassium gives yeast extract 8 days using continuous gavage and end Secondary intraperitoneal injection Oteracil Potassium establishes Studies on Animal Models of Hyperuricemic Mice, and loose Pueraria lobota anti-trioxypurine extract is given in stomach-filling, and (7.5 g are extracted Object/kg, 5.0 g extracts/kg, 2.5 g extracts/kg), successive administration 8 days, loose Pueraria lobota anti-trioxypurine extract 7.5g/kg can drop Low hyperuricemia model mice serum UA, Cr, BUN content reduces serum and liver XOD, liver ADA activity, loose Pueraria lobota anti-trioxypurine 5.0 g/kg of extract can reduce serum UA, Cr, BUN, TC, TG content, reduce serum XOD, serum and liver ADA activity, loose Pueraria lobota 2.5 g/kg of anti-trioxypurine extract can reduce serum UA, BUN, TG content, reduce liver ADA activity.
Test example 2
Influence to high purine feed cause hyperuricemia model rat is fed establishes rat in 27 days using high purine feed is continuously fed Loose Pueraria lobota anti-trioxypurine extract (5.25 g extracts/kg, 3.50 g extracts/kg, 1.75 are given in hyperuricemia model, stomach-filling G extract/kg), successive administration 27 days, loose three dosage of Pueraria lobota anti-trioxypurine extract (5.25,3.50,1.75 g/kg) can be dropped Low rat model serum UA, Cr, BUN, TC, TG content reduces serum and liver XOD, serum ADA activity, reduces basic, normal, high Whole blood viscosity and plasma viscosity under shear rate increase serum NO levels, loose Pueraria lobota anti-trioxypurine extract (3.50,1.75 g/kg) Liver ADA activity can be reduced.

Claims (2)

1. the method that thick grass acid content improves in loose Pueraria lobota anti-trioxypurine particle preparation, it is characterised in that steps are as follows:
A, the traditional Chinese medicinal material raw materials for preparing pine needle, pueraria lobata, dried orange peel 4.5~4.75:4.5 in mass ratio~4.75:0.5~1 crush Afterwards, 45~60 meshes are crossed, traditional Chinese medicinal material raw materials powder is obtained, is fitted into supercritical extraction reactor;
B, it is extracted in supercritical extraction reactor, extraction temperature is 35~55 DEG C, CO2Fluid pressure is 30~60MPa, entrainer stream 0.1~0.6ml/min of speed, 2~4h of extraction time, extract is absorbing liquid, methanol and traditional Chinese medicinal material raw materials powder with methanol absorption Volume mass ratio be 1ml:2g;The entrainer by ethyl alcohol, hexamethylene, petroleum ether, water according to mass ratio 5:1:1:3 prepare and At;
C, absorbing liquid with D101 type macroreticular resin chromatograph, per hour the distilled water of two bed volume flow velocitys be eluted to efflux without Color, then pillar is washed with the ethyl alcohol of the mass percentage concentration 75% of 10 bed volumes, ethanol eluate is under the conditions of 450~500Pa It is concentrated under reduced pressure into and closely does, 105 DEG C of dryings for 24 hours, obtain faint yellow loose Pueraria lobota anti-trioxypurine extract.
2. the method that thick grass acid content improves in pine Pueraria lobota anti-trioxypurine particle preparation as described in claim 1, it is characterised in that step In rapid b, extraction temperature is 45 DEG C, CO2Fluid pressure is 43MPa, entrainer ethyl alcohol flow velocity 0.45ml/min, extraction time 2.6h。
CN201811562974.3A 2018-12-20 2018-12-20 The method that thick grass acid content improves in loose Pueraria lobota anti-trioxypurine particle preparation Pending CN109512878A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811562974.3A CN109512878A (en) 2018-12-20 2018-12-20 The method that thick grass acid content improves in loose Pueraria lobota anti-trioxypurine particle preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811562974.3A CN109512878A (en) 2018-12-20 2018-12-20 The method that thick grass acid content improves in loose Pueraria lobota anti-trioxypurine particle preparation

Publications (1)

Publication Number Publication Date
CN109512878A true CN109512878A (en) 2019-03-26

Family

ID=65796986

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811562974.3A Pending CN109512878A (en) 2018-12-20 2018-12-20 The method that thick grass acid content improves in loose Pueraria lobota anti-trioxypurine particle preparation

Country Status (1)

Country Link
CN (1) CN109512878A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112043599A (en) * 2020-09-02 2020-12-08 广东微纳生物科技有限公司 Method for preparing uric acid-reducing powder by nanotechnology and processing equipment

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103191235A (en) * 2013-03-29 2013-07-10 宁波泰康红豆杉生物工程有限公司 Traditional Chinese medicine compound extract for preventing and treating hyperuricemia and application

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103191235A (en) * 2013-03-29 2013-07-10 宁波泰康红豆杉生物工程有限公司 Traditional Chinese medicine compound extract for preventing and treating hyperuricemia and application

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JOHANNA SCHEUBA, ET AL.: "fast and green-CO2 based extraction, isolation, and quantification of phenolic styrax constituents", 《PLANTA MED》 *
宋航: "《制药分离工程》", 31 August 2011, 华东理工大学出版社 *
张迎等: "八角莽草酸提取、分离、纯化及其功能性研究进展", 《粮食与油脂》 *
祝洪艳等: ""五味子超临界萃取部位化学成分研究"", 《中药材》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112043599A (en) * 2020-09-02 2020-12-08 广东微纳生物科技有限公司 Method for preparing uric acid-reducing powder by nanotechnology and processing equipment

Similar Documents

Publication Publication Date Title
CN102617667B (en) Method for simultaneously preparing total caffeoylquinic acid and stevioside by taking stevia as raw material
CN102351824B (en) Method for preparing lactuca indica and lactucin
CN103013669B (en) Preparation method of tobacco leaf moisturizing liquor for lowering tar content and benzopyrene content
CN104592323B (en) A kind of method of phloridzin in aqueous two-phase extraction pomace
CN103520233A (en) Preparation method and application of apocynum venetum leaf total polyphenol
CN109602803A (en) The method that limonin content improves in loose Pueraria lobota anti-trioxypurine particle preparation
CN109512878A (en) The method that thick grass acid content improves in loose Pueraria lobota anti-trioxypurine particle preparation
CN104211690B (en) Method for separating and purifying mangiferin from aquilaria sinensis leaves
CN106831909B (en) The extracting method of double benzene pyrrones compounds in rhizoma anemarrhenae fibrous root
CN101530193A (en) Method for comprehensively extracting and purifying oxidation-resistant active ingredient in sugarcane toppers or slag
CN106617060A (en) Fructus phyllanthi polyphenols enriching and purifying method
CN109512879A (en) The method that isoflavone content improves in loose Pueraria lobota anti-trioxypurine particle preparation
CN109602802A (en) The method that flavones content improves in loose Pueraria lobota anti-trioxypurine particle preparation
CN101708215A (en) Method for extracting triterpenes from schisandra chinansis
CN102432419B (en) Method for extracting and separating beta-elemene from Eupatorium adenophorum
CN103553893B (en) Method for extracting raspberry ketone from raspberry
CN102702289A (en) Method for purifying three types of flavonoid glycosides from large-leaf poacynum leaves by applying high-speed counter-current chromatography
CN102432420B (en) Method for extracting and separating beta-elemene from Lantana camara
CN109453234A (en) Root bark of white mulberry product and preparation method thereof
CN106668117A (en) Supercritical extraction method capable of improving taste ability of fructus phyllanthi polyphenol
CN1943647B (en) The method for preparing triterpenic acid extract from the loquat leaves
CN102836204B (en) Kudzuvine root extracts and preparation thereof
CN106749487A (en) A kind of method that separating ursolic acid is extracted from seabuckthorn fruit peel
CN104547204A (en) Method for extracting polyphenol substances from litchi pericarp
CN105106653A (en) Preparation method of anoectochilus roxburghii granules

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190326

RJ01 Rejection of invention patent application after publication